Pharming Group announces completion of minority investment in BioConnection BV

Wednesday, April 10, 2019

Pharming announces that it has completed its investment of €1.6 million in cash and conversion of €2.5 million of prepayments into new equity in its Fill & Finish partner BioConnection BV.

Pharming announces that following the Company’s announcement on 29 March 2019, it has completed its investment of €1.6 million in cash and conversion of €2.5 million of prepayments into new equity in its Fill & Finish partner BioConnection BV, which manufactures the sterile sealed vials of Pharming’s product RUCONEST® from the purified drug substance.

Read more

Come and join us, find your next challenging job in our Job board. There is plenty of interesting and rewarding work in life sciences in Leiden.

Find a job